Laffer Tengler Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-265
Closed -$32.4K 411
2023
Q2
$32.4K Sell
265
-28,068
-99% -$3.5M 0.01% 335
2023
Q1
$3.42M Sell
28,333
-75
-0.3% -$8.63K 0.93% 33
2022
Q4
$3.26M Sell
28,408
-1,239
-4% -$137K 0.94% 36
2022
Q3
$3.03M Sell
29,647
-1,040
-3% -$110K 1.11% 21
2022
Q2
$3.12M Buy
30,687
+38
+0.1% +$4.14K 1.1% 22
2022
Q1
$3.57M Buy
30,649
+142
+0.5% +$16.4K 1.08% 18
2021
Q4
$3.49M Sell
30,507
-238
-0.8% -$27.1K 1.01% 22
2021
Q3
$3.58M Sell
30,745
-613
-2% -$72.7K 1.03% 20
2021
Q2
$3.62M Buy
31,358
+5,223
+20% +$597K 1.36% 13
2021
Q1
$2.82M Sell
26,135
-948
-4% -$105K 1.07% 34
2020
Q4
$2.95M Buy
27,083
+6,136
+29% +$664K 1.25% 25
2020
Q3
$2.34M Buy
20,947
+752
+4% +$84.3K 1.17% 33
2020
Q2
$2.11M Buy
+20,195
New +$2.16M 1.21% 35

Laffer Tengler Investments's BSX.PRA Position: Q3 2023 in Review

Laffer Tengler Investments sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2023, closing a stake of 265 shares — an estimated $32.4K sold.

Laffer Tengler Investments first reported a position in BSX.PRA in Q2 2020 and held it in 13 quarters. The position peaked at $3.62M in Q2 2021. 0 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2023.

  • Laffer Tengler Investments reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2023 after selling out during the quarter.
  • Laffer Tengler Investments sold 265 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2023, an estimated $32.4K.
  • Laffer Tengler Investments first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 13 quarters.
  • Laffer Tengler Investments's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.62M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2023.

Based on Laffer Tengler Investments's 13F filing for Q3 2023, filed 14 Nov 2023.